Hepatitis-associated antigen (Q39885067)

15 September 2017

2 references

26 October 2022

Hepatitis-associated antigen (English)

1 reference

15 September 2017

N R Shulman

1

1 reference

PubMed ID

4250361

15 September 2017

language of work or name

English

0 references

publication date

1 November 1970

2 references

American Journal of Medicine

15 September 2017

26 October 2022

2 references

15 September 2017

26 October 2022

49

1 reference

15 September 2017

669-692

1 reference

A "NEW" ANTIGEN IN LEUKEMIA SERA

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Association between lepromatous leprosy and Australia antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Observations on Australia Antigen in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

An antigen detected in the blood during the incubation period of serum hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Virus-like particles in sera of patients with infectious and serum hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Viral hepatitis and the Australia-SH antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia antigen (a hepatitis-associated antigen): purification and physical properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Preparation and Characterization of Complement-fixing Hepatitis-associated Antigen and Antiserum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

The size of serum hepatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia Antigen: Distribution during Cohn Ethanol Fractionation of Human Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia antigen in acute and chronic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Studies of Australia-SH Antigen in Sporadic Viral Hepatitis in London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Relation of Australia-SH antigen to the willowbrook MS-2 strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis antigen. Detection of infectious blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis-associated antigen in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Failure to detect an Antigen associated with Hepatitis in a Community Epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Homologous serum hepatitis and infectious (epidemic) hepatitis; studies in volunteers bearing on immunological and other characteristics of the etiological agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Transmission of serum hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Progression of acute hepatitis to postnecrotic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

7 January 2021

inferred from DOI database lookup

Australia antigen in chronic active liver disease with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia Antigen in Chronic Hepatitis in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Prognosis of chronic persistent hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Serum Hepatitis Antigen (SH): Rapid Detection by High Voltage Immunoelectroosmophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Immunoelectrophoretic detection of the "hepatitis associated antigen" (Au-SH-antigen)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

7 January 2021

Active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia antigen as a hepatitis virus. Variation in host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

MODIFICATION OF POST-TRANSFUSION HEPATITIS BY GAMMA GLOBULIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis in marmosets: induction of disease with coded specimens from a human volunteer study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

HEPATITIS DUE TO THE INJECTION OF HOMOLOGOUS BLOOD PRODUCTS IN HUMAN VOLUNTEERS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis-Associated Antigen (Australia Antigen) in Mother and Infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Failure of Australia antibody to prevent post-transfusion hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Detection of Australia Antigen and Antibody by Means of Radioimmunoassay Techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Immune complexes in hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia Antigen–Antibody Complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Measles as an index of immunological function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Infectious virus-antibody complex in the blood of chronically infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia-SH antigen and liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Rapid screening test for detecting hepatitis-associated antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

A complement-fixation test for measuring Australia antigen and antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

The localization of Australia antigen by immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Production of antibody against "Australia antigen" in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Chimpanzee Antibodies to Australia Antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Additional specificities of Australia antigen and the possible identification of hepatitis carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Presence of particles other than the Australia-SH antigen in a case of chronic active hepatitis with cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2870%2980133-4

Hepatitis and leukemia: their relation to Australia antigen

7 January 2021

1 reference

12 December 2020

S.H. antigen in haemodialysis-associated hepatitis

1 reference

12 December 2020

Viral hepatitis. New light on an old disease

1 reference

12 December 2020

An outbreak of infectious hepatitis among chimpanzee handlers at a United States Air Force Base

1 reference

12 December 2020

Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen

1 reference

12 December 2020

Further studies on a "new" human isoprecipitin system (Australia antigen)

1 reference

12 December 2020

Prevalence of Serum-Hepatitis-Related Antigen (SH) in Different Geographic Regions *

1 reference

12 December 2020

Biophysical properties of Australia antigen

1 reference

12 December 2020

The role of serum hepatitis virus in chronic liver disease

1 reference

12 December 2020

Family studies of a human serum isoantigen system (Australia antigen).

1 reference

12 December 2020

1 reference

12 December 2020

Some antigenic and physical properties of virus-like particles in sera of hepatitis patients

1 reference

12 December 2020

Properties of a small virus associated with adenovirus type 4.

1 reference

12 December 2020

An epidemic of serum hepatits studied under controlled conditions

1 reference

12 December 2020

Rapid detection of Australia antigen by counterimmunoelectrophoresis

1 reference

12 December 2020

Hepatitis antigen. Correlation with disease and infectivity of blood-donors

1 reference

12 December 2020

10.1016/S0002-9343(70)80133-4

Identifiers

DOI

1 reference

15 September 2017

0 references

1 reference

PubMed ID

4250361